Stroke (ischemic)

Ischemic stroke occurs when a blood clot blocks an artery supplying blood to the brain, leading to cell death and potentially severe disability or death.

Research indicates that ischemic stroke involves complex mechanisms including inflammation and oxidative stress, which contribute to neuronal injuries and cell death in affected areas of the brain. Studies also highlight various signaling pathways and molecular interactions that play critical roles in both causing and potentially treating ischemic stroke. Interleukins, a type of cytokine involved in immune responses, have been identified as significant factors influencing the inflammatory process during strokes.

This condition is strongly linked to increased mortality rates and is often caused by inflammation and oxidative stress. These connections underscore the importance of addressing these underlying issues for prevention and treatment strategies.

The evidence base primarily relies on observational studies, which limits definitive conclusions about causality and treatment efficacy.

Sources

• Management of Acute Ischemic Stroke. (PMID:32947473)
• Neuronal injuries in cerebral infarction and ischemic stroke: From mechanisms to treatment (Review). (PMID:34878154)
• Ischemic Stroke. (PMID:34454905)
• Interleukins and Ischemic Stroke. (PMID:35173738)
• Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions. (PMID:35794095)
• Ischemic Stroke in Young Adults. (PMID:32224758)

_Worker-drafted node, Hermes writer enrichment, pending editorial review._